Literature DB >> 29023363

LPS-Induced Systemic Inflammation Does Not Alter Atherosclerotic Plaque Area or Inflammation in APOE3*LEIDEN Mice in the Early Phase Up to 15 Days.

Wessel W Fuijkschot1,2,3, Martine C Morrison4, Ilse P A Zethof1, Paul A J Krijnen1,2, Robert Kleemann4, Hans W M Niessen1,2,5, Yvo M Smulders2,3.   

Abstract

BACKGROUND AND AIMS: Observational studies show a peak incidence in cardiovascular events during and early after clinical conditions associated with substantial systemic inflammation, such as pneumonia. The acuteness of this increased risk suggests rapid plaque destabilization and associated intraplaque inflammation. We evaluated whether lipopolysaccharides (LPS)-evoked acute systemic inflammation would induce such detrimental vascular changes in murine aortas with manifest atherosclerotic lesions. METHODS AND
RESULTS: ApoE3*Leiden mice were fed a high cholesterol diet for 20 weeks to establish atherosclerosis. Thereafter, mice received a single intraperitoneal injection with LPS to induce systemic inflammation, or saline for control. Mice were sacrificed 2 or 15 days post-LPS injection (n = 17) or post-saline injection (n = 13). Serum amyloid A, a sensitive marker of systemic inflammation, increased 250-fold in LPS-treated mice. Aortic root plaques were assessed for total plaque area, plaque severity, and inflammatory cell content. No significant differences in total surface area of atherosclerotic plaque were found between control and LPS groups sacrificed after 2 days (resp. 0.409 ± 0.228 × 10 μm vs. 0.285 ± 0.169 × 10 μm) (P = 0.31), and 15 days (resp. 0.950 ± 0.938 × 10 μm vs. 0.612 ± 0.413 × 10 μm) (P = 0.80). Furthermore, plaque type and number of lesions were unaltered and intraplaque density of macrophages and lymphocytes were comparable in both the groups.
CONCLUSIONS: Intraperitoneal LPS injection in ApoE3*Leiden mice triggers a profound systemic inflammatory response, but does not increase atherosclerotic plaque area or inflammatory cell density. This model of LPS-induced inflammation in atherosclerosis-prone mice argues against intraplaque alterations as an explanation for acute inflammation-induced cardiovascular event risk.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29023363     DOI: 10.1097/SHK.0000000000001026

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

Review 1.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

Review 2.  Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.

Authors:  Francesco Violi; Vittoria Cammisotto; Simona Bartimoccia; Pasquale Pignatelli; Roberto Carnevale; Cristina Nocella
Journal:  Nat Rev Cardiol       Date:  2022-07-15       Impact factor: 49.421

3.  Obese Animals as Models for Numerous Diseases: Advantages and Applications.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Medicina (Kaunas)       Date:  2021-04-21       Impact factor: 2.430

4.  Establishment of inflammatory model induced by Pseudorabies virus infection in mice.

Authors:  Chun Zhi Ren; Wen Yue Hu; Jin Wu Zhang; Ying Yi Wei; Mei Ling Yu; Ting Jun Hu
Journal:  J Vet Sci       Date:  2021-03       Impact factor: 1.672

Review 5.  Gut Microbiota and Environment in Coronary Artery Disease.

Authors:  Andrea Piccioni; Tommaso de Cunzo; Federico Valletta; Marcello Covino; Emanuele Rinninella; Pauline Raoul; Christian Zanza; Maria Cristina Mele; Francesco Franceschi
Journal:  Int J Environ Res Public Health       Date:  2021-04-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.